Stalemate over PBS pricing emerges

Growing calls for Novo Nordisk’s Wegovy and Eli Lilly’s Mounjaro to be added to the PBS for weight loss have put the Government under mounting pressure, with Health Minister Mark Butler saying this “revolutionary class of drugs” must be subsidised “at some point”, as negotiations over pricing stall.

To see the whole article please log in.

Tiffany Walker

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Retype password

Not a member? Sign up here